Director, PRO Consortium, Critical Path Institute, United States
Sonya Eremenco is Director of the Patient-Reported Outcome (PRO) Consortium. Sonya has over 20 years of experience in PRO (and other clinical outcome assessment) instrument development, with a focus on multicultural development, linguistic validation, and electronic implementation...
Read More →PK
Senior Vice President, Biometrics and Development Strategy, Ultragenyx Pharmaceutical, United States
P. K. Tandon, Ph.D. is Senior Vice President of Biometrics and Development Strategy at Ultragenyx Pharmaceuticals, Inc. based in Cambridge, MA. He joined Ultragenyx Pharmaceuticals in January, 2017. Prior to Ultragenyx, he was Clinical Science Officer and SVP at Sanofi-Genzyme and...
Read More → AK
Scientific Advisor, Signant Health, United Kingdom
Alexandra Kalpadakis-Smith is a Scientific Advisor at Signant Health, where she provides scientific expertise on digitising the capture of Clinical Outcome Assessments (COA) and the use of connected health devices in clinical trials. She participates in research activities on the...
Read More →